Becotatug Vedotin Plus Pucotenlimab for Advanced Biliary Tract Cancer, Phase II

NCT07649980 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Biliary Tract Cancer (BTC)
EGFR-positive Advanced Biliary Tract Carcinoma

Interventions

DRUG: Becotatug Vedotin
DRUG: Pucotenlimab

Sponsor

HuiKai Li